Identification of causal intervention effects under contagion
暂无分享,去创建一个
[1] M E Halloran,et al. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. , 1997, American journal of epidemiology.
[2] Ilya Shpitser,et al. Modeling Interference Via Symmetric Treatment Decomposition , 2017, 1709.01050.
[3] Elja Arjas,et al. Transmission of Pneumococcal Carriage in Families: A Latent Markov Process Model for Binary Longitudinal Data , 2000 .
[4] Greenwood,et al. The Statistics of Anti-Typhoid and Anti-Cholera Inoculations, and the Interpretation of Such Statistics in General , 1915, Proceedings of the Royal Society of Medicine.
[5] M. Halloran,et al. Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. , 1994, Statistics in medicine.
[6] Eben Kenah,et al. Nonparametric survival analysis of epidemic data , 2013 .
[7] Claudio J. Struchiner,et al. Design and Analysis of Vaccine Studies , 2009 .
[8] M. Halloran,et al. Causal Inference in Infectious Diseases , 1995, Epidemiology.
[9] D. Rubin. Causal Inference Using Potential Outcomes , 2005 .
[10] C. Viboud,et al. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data , 2004, Statistics in medicine.
[11] J. Pearl,et al. Causal inference , 2011, Twenty-one Mental Models That Can Change Policing.
[12] I M Longini,et al. Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. , 1988, American journal of epidemiology.
[13] T. VanderWeele,et al. Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. , 2012, Epidemiology.
[14] Michael G Hudgens,et al. Causal Inference for Vaccine Effects on Infectiousness , 2012, The international journal of biostatistics.
[15] M. Halloran,et al. Design and interpretation of vaccine field studies. , 1999, Epidemiologic reviews.
[16] I M Longini,et al. Estimating household and community transmission parameters for influenza. , 1982, American journal of epidemiology.
[17] Judea Pearl,et al. Direct and Indirect Effects , 2001, UAI.
[18] Eben Kenah,et al. Contact intervals, survival analysis of epidemic data, and estimation of R(0). , 2009, Biostatistics.
[19] Elizabeth L. Ogburn,et al. Causal diagrams for interference , 2014, 1403.1239.
[20] M. Elizabeth Halloran,et al. Counting Process Models for Infectious Disease Data: Distinguishing Exposure to Infection from Susceptibility , 1996 .
[21] Semiparametric Methods for Multiple Exposure Mismeasurement and a Bivariate Outcome in HIV Vaccine Trials , 1999, Biometrics.
[22] Eben Kenah. Semiparametric Relative-Risk Regression for Infectious Disease Transmission Data , 2015, Journal of the American Statistical Association.
[23] J. Robins,et al. Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.
[24] B. Cowling,et al. Individual Correlates of Infectivity of Influenza A Virus Infections in Households , 2016, PloS one.
[25] T J VanderWeele,et al. Direct and Indirect Effects for Neighborhood-Based Clustered and Longitudinal Data , 2010, Sociological methods & research.
[26] Simon Cauchemez,et al. Investigating Heterogeneity in Pneumococcal Transmission , 2006 .
[27] Y. Chiba. A Simple Method of Measuring Vaccine Effects on Infectiousness and Contagion , 2013 .
[28] M. Elizabeth Halloran,et al. Dependent Happenings: a Recent Methodological Review , 2016, Current Epidemiology Reports.
[29] J. Peiris,et al. Influenza A Virus Shedding and Infectivity in Households. , 2015, The Journal of infectious diseases.
[30] J. Robins,et al. Generation interval contraction and epidemic data analysis. , 2007, Mathematical biosciences.
[31] David R. Cox. Planning of Experiments , 1958 .
[32] I M Longini,et al. A discrete-time model for the statistical analysis of infectious disease incidence data. , 1992, Biometrics.
[33] Tyler J. VanderWeele,et al. Bounding the Infectiousness Effect in Vaccine Trials , 2011, Epidemiology.
[34] M E Halloran,et al. Study designs for dependent happenings. , 1991, Epidemiology.
[35] M. Akritas. Nonparametric Survival Analysis , 2004 .
[36] Ilya Shpitser,et al. Causal Inference Under Interference And Network Uncertainty , 2019, UAI.
[37] T. Francis. Evaluation of the 1954 poliomyelitis vaccine field trial; further studies of results determining the effectiveness of poliomyelitis vaccine (Salk) in preventing paralytic poliomyelitis. , 1955, Journal of the American Medical Association.
[38] Ilya Shpitser,et al. Identification and Estimation of Causal Effects from Dependent Data , 2018, NeurIPS.
[39] M E Halloran,et al. Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.
[40] M. Hudgens,et al. Assessing effects of cholera vaccination in the presence of interference , 2014, Biometrics.
[41] Forrest W. Crawford,et al. Risk ratios for contagious outcomes , 2017, Journal of The Royal Society Interface.
[42] A. Sjölander,et al. Carryover Effects in Sibling Comparison Designs. , 2016, Epidemiology.
[43] M. Hudgens,et al. Toward Causal Inference With Interference , 2008, Journal of the American Statistical Association.
[44] Tyler J. VanderWeele,et al. Vaccines, Contagion, and Social Networks , 2014, ArXiv.
[45] Y. Chiba. A note on bounds for the causal infectiousness effect in vaccine trials , 2012 .
[46] M Elizabeth Halloran,et al. Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups , 2006, Journal of the Royal Statistical Society. Series C, Applied statistics.
[47] D. Balding,et al. Analyses of infectious disease data from household outbreaks by Markov chain Monte Carlo methods , 2000 .
[48] Elizabeth L. Ogburn. Challenges to Estimating Contagion Effects from Observational Data , 2017, 1706.08440.
[49] Elizabeth L. Ogburn,et al. Causal inference, social networks, and chain graphs. , 2018 .
[51] C. Fraser,et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. , 2009, The New England journal of medicine.